Loa loa filariasis

For patient information, click here

Loa Loa Filariasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Loa Loa Filariasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Loa loa filariasis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Loa loa filariasis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Loa loa filariasis

CDC on Loa loa filariasis

Loa loa filariasis in the news

Blogs on Loa loa filariasis

Directions to Hospitals Treating Loa loa filariasis

Risk calculators and risk factors for Loa loa filariasis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:  Kalsang Dolma, M.B.B.S.[2]

Synonyms and keywords: African eye worm; loaiasis; loiasis; loaina; filaria loa; filaria lacrimalis; filaria subconjunctivalis; fugitive swellings; microfilaria diurnal

## Overview

[edit | edit source]

## Historical Perspective

[edit | edit source]

## Pathophysiology

[edit | edit source]

## Causes

[edit | edit source]

## Differentiating Loa Loa Filariasis from other Diseases

[edit | edit source]

## Epidemiology and Demographics

[edit | edit source]

## Risk Factors

[edit | edit source]

## Natural History, Complications and Prognosis

[edit | edit source]

## Diagnosis

[edit | edit source]

History and Symptoms |  Physical Examination | Laboratory Findings | Other Diagnostic Studies

## Treatment

[edit | edit source]

Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

* Cutaneous filariasis - Loa loa, onchocercia volvulus[1][2]

* Preferred regimen (1): Doxycycline 150 μg/kg single dose
* Preferred regimen (2): (Doxycycline 100 mg PO qd for 6 weeks OR 200 mg PO qd for 4 weeks) THEN Ivermectin after 4-6 months 150 μg/kg single dose
* Preferred regimen (3): Doxycycline 200 mg PO qd for 6 weeks THEN Ivermectin after 4-6 months 150 μg/kg single dose

## Case Studies

[edit | edit source]

Case #1

## External Links

[edit | edit source]

* CDC Fact Sheet

de:Loiasis

Template:WH Template:WS

## References

[edit | edit source]

1. ↑ Taylor MJ, Hoerauf A, Bockarie M (2010). "Lymphatic filariasis and onchocerciasis". Lancet. 376 (9747): 1175–85. doi:10.1016/S0140-6736(10)60586-7. PMID 20739055.CS1 maint: Multiple names: authors list (link)
2. ↑ Knopp S, Steinmann P, Hatz C, Keiser J, Utzinger J (2012). "Nematode infections: filariases". Infect Dis Clin North Am. 26 (2): 359–81. doi:10.1016/j.idc.2012.02.005. PMID 22632644.CS1 maint: Multiple names: authors list (link)